Most current drug therapy development is based on research of genes that were discovered in 1987 and are responsible for early onset Alzheimer's disease, which accounts for only 5-10% of the total Alzheimer's population.
Join our mailing list
By adding your email address to our list, you will receive periodic mailings including our Annual Report and our Quarterly Reports.